Britain's health cost watchdog NICE will be responsible for assessing the full value of medicines under a value-based pricing system for new drugs due to take effect from 2014, the government said on Thursday.
http://www.courant.com/health/sns-rt-us-britain-medicinesbre92k0uc-20130321,0,3574631.story
No comments:
Post a Comment